Innovent Biologics Expands Access to Seven New Treatments in China Innovent Biologics announces the inclusion of seven innovative therapies in China's National Reimbursement Drug List, enhancing patient access to essential medications.

Innovent Biologics Expands Access to Seven New Treatments in China #China #Suzhou #Innovent_Biologics #SYCUME #TYVYT